Back to search
Bardet Biedl Syndrome (BBS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Bardet Biedl Syndrome (BBS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Bardet Biedl Syndrome (BBS) trials you may qualify forBardet-Biedl Syndrome (BBS) is an uncommon genetic disorder that affects multiple organs. and presents with a variety of characteristics. It is caused by a dysf…
This pivotal, phase 3 study is designed to confirm the efficacy and safety of setmelanotide, a potent melanocortin receptor type 4 (MC4R) agonist, for the treat…
An open-label, single-arm, multicenter, Expanded Access Protocol \[EAP\] designed to provide treatment access to setmelanotide (3 mg, administered subcutaneousl…
This study will evaluate patients with a rare inherited condition called Bardet-Biedl syndrome . The purpose of the study is to learn more about the genetics an…